2001•ACP Journal ClubRequires access

Review: Budesonide is better than mesalazine but not conventional corticosteroids for inducing remission in active Crohn disease

Brian G. Feagan

Abstract

Source Citation Papi C, Luchetti R, Gili L, et al. Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther. 2000 Nov;14:1419-28. 11069312 (All 2001 articles were reviewed for relevancy, and abstracts were last revised in 2007.)

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Mesalazine, Budesonide, Medicine, Crohn's disease, Internal medicine, Gastroenterology, Crohn disease, Disease

Back to paper search Browse research topics Original source

Review: Budesonide is better than mesalazine but not conventional corticosteroids for inducing remission in active Crohn disease — Research Paper | ScholarLens